In addition, in vitro experiments showed that miR-217 promotes the accumulation of histone deacetylase 5 (HDAC5) in the nucleus by targeting MEF2D, resulting in decreased expression of IL-10, thereby aggravating cognitive dysfunction after cerebral ischemia. Here, HDAC5 is linked to brain ischemia.